Epigenetic Signatures Differentiate Leiomyosarcoma Subtypes
In the cover paper chosen for Oncotarget’s Volume 12, Issue 16, researchers from Yale... read more
By Kathryn Atkins
August 4, 2021
Oncotarget News
Table of Contents: Oncotarget’s Volume 12, Issue #16
Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more
By Oncotarget
August 3, 2021
Biomarker Predicts Treatment Efficacy in Triple-Negative Breast Cancer
In this 2020 paper, researchers searched for biomarkers of sacituzumab govitecan treatment efficacy in triple-negative... read more
By Kathryn Atkins
July 27, 2021
Metal Compounds Induce DNA Instability In Cancer Cells
Telomeres are the protective end-caps that seal the DNA’s genetic information. Located at... read more
By Kathryn Atkins
July 21, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #15
Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more
By Oncotarget
July 20, 2021
Trending With Impact: Targeted Treatment for Recurrent Ovarian Cancer
In this 2018 paper, researchers studied a new targeted strategy to treat ovarian cancer.The&... read more
By Kathryn Atkins
July 15, 2021
Acid Reflux Drug Exhibits Anticancer Activity
In the cover paper of Oncotarget's Volume 12, Issue 14, researchers repurposed an over-the-counter acid... read more
By Kathryn Atkins
July 7, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #14
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
By Kathryn Atkins
July 6, 2021
Behind the Study: ONC201, TRAIL, and Breast Cancer
Founding Oncotarget Editorial Board Member, Dr. Wafik S. El-Deiry, and recent MD/PhD graduate of... read more
By Oncotarget
July 5, 2021
Trending With Impact: ONC201 Induces Apoptosis in Breast Cancer
A novel therapeutic combination converts anti-proliferative effects in breast cancer cells to pro-apoptotic.The Trending... read more
By Kathryn Atkins
July 1, 2021